![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
A61K 31/519 | |||
A61P 35/00 |
(11) | Number of the document | 2486041 |
(13) | Kind of document | T |
(96) | European patent application number | 10765557.3 |
Date of filing the European patent application | 2010-10-08 | |
(97) | Date of publication of the European application | 2012-08-15 |
(45) | Date of publication and mention of the grant of the patent | 2013-08-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/052011 |
Date | 2010-10-08 |
(87) | Number | WO 2011/044481 |
Date | 2011-04-14 |
(30) | Number | Date | Country code |
250387 P | 2009-10-09 | US | |
316218 P | 2010-03-22 | US |
(72) |
RODGERS, James, D., US
SHILLING, Adam, US
ARVANITIS, Argyrios, G., US
SHEPARD, Stacey, US
GALYA, Laurine, G., US
LI, Mei, US
NEDZA, Frank, M., US
|
(73) |
Incyte Corporation,
Experimental Station Route 141 & Henry Clay Road Building E336/207, Wilmington, DE 19880,
US
|
(54) | HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |